Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on the tablet surface ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for raltegravir ...

Granules India receives US FDA's ANDA approval for Trazodone Hydrochloride Tablets USP, 50 mg, 100 mg, 150 mg, 300 mg Trazodone tablets are indicated for the treatment of major depressive disorder ...

Hydrochlorothiazide oral tablet is prescribed to treat high blood pressure and swelling. Learn about side effects, warnings, dosage, and more.

Usfda: Aripiprazole Tablets USP are indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder, adjunctive treatment of major ...

The US Food & Drug Administration (USFDA) has approved its abbreviated new drug application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg, and ...

The American medicine regulatory body has “approved the Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 ...

Drugmaker Granules India has received U.S. Food and Drug Administration (U.S. FDA) approval for its abbreviated new drug application for Losartan and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg ...

Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ...

The product will be manufactured at Lupin’s Pithampur facility in India. Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S.

This time the company is Aurobindo Pharma USA, Inc. The blood pressure medication being recalled is Quinapril and Hydrochlorothiazide Tablets USP in 20 mg and 12.5 mg doses, respectively.